New York Times(US:NYT) TMX Newsfile·2026-02-08 18:39Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Picard Medical, Inc. due to allegations of securities law violations, encouraging affected investors to come forward [2][4]. Group 1: Legal Investigation - The law firm is urging investors who suffered losses exceeding $50,000 from purchasing Picard Medical securities between September 2, 2025, and October 31, 2025, to contact them for legal options [1]. - A federal securities class action has been filed against Picard Medical, with a deadline of April 3, 2026, for investors to seek the role of lead plaintiff [2][5]. Group 2: Allegations Against Picard Medical - The complaint alleges that Picard Medical and its executives made false and misleading statements, failing to disclose involvement in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [4]. - It is claimed that insiders and affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign, and that the company's public statements omitted critical information regarding false rumors and artificial trading activity affecting stock prices [4]. Group 3: Firm Background - Faruqi & Faruqi, LLP is a prominent national securities law firm with a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [3].